z-logo
open-access-imgOpen Access
Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations or Future HIV Remission Options
Author(s) -
K. Dubé,
D. M. Campbell,
K. E. Perry,
J. T. Kanazawa,
P. Saberi,
J. A. Sauceda,
T. Poteat,
D. Evans
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/xjd3-8075
Subject(s) - antiretroviral therapy , human immunodeficiency virus (hiv) , medicine , antiretroviral treatment , psychology , family medicine , viral load

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom